Milestone in ovarian cancer application
This morning Angle reported initial results from its two lead clinical trials with Parsortix, a liquid biopsy system. The two studies ran in...
226 Views
A boost for prostate cancer indication
Yesterday Angle announced that researchers from Queen Mary University of London's Barts Cancer Institute (BCI) published new data further...
200 Views
Data from ovarian cancer studies in Q217
Angle’s H117 business update revealed that R&D activities are progressing well, while the company booked further research use sales. The first...
289 Views
Data from ovarian cancer studies in Q217
Angle’s H117 business update revealed that R&D activities are progressing well, while the company booked further research use sales. The first...
137 Views